European Archives - Page 2 of 1492 - European Medical Journal

Child-Pugh B HCC: Atezolizumab/Bevacizumab Outcomes

A multicentre study suggests selected Child-Pugh B liver cancer patients may benefit from first-line atezolizumab/bevacizumab despite poorer survival outcomes.

Pollen Linked to Coronavirus Spread in Nasal Cells: EAACI 2026

Pollen exposure may enhance the spread of coronavirus infections within the nasal lining by weakening antiviral immune responses.

Sickle cell disease

Mitapivat Improves Anaemia in Sickle Cell Disease: EHA 2026

Learn how a Phase 3 trial shows mitapivat significantly improves anaemia and haemolysis in sickle cell disease.

mRNA Therapy Shows Potential to Reprogram Allergic Responses

Researchers report that combining allergen-specific mRNA therapy with mTOR inhibition enhanced immune tolerance and reduced allergic inflammation in a preclinical asthma model.

Women with Systemic Sclerosis Face Higher Pregnancy Risks

Women with systemic sclerosis face increased risks at pregnancy and a greater likelihood of reproductive hormone imbalances and sexual dysfunction, new research has found.

AI Could Help Detect Athletes at Risk of Sudden Cardiac Death

Researchers suggest combining explainable AI with digital heart models could improve screening for athletes at risk of sudden cardiac death.

Food Allergy Training Boosts School Preparedness - EMJ

Online Training Aids Allergy Knowledge Among School Staff: EAACI 2026

A nationwide online food allergy training programme significantly improved school staff knowledge and confidence in managing allergic emergencies.

Skin Cancer Diagnosis AI Falls Short of Experts - EMJ

Experts Outperform AI in Real-World Skin Cancer Detection

Modern AI models can outperform junior clinicians in skin cancer diagnosis but remain less accurate than experienced dermatologists.

Remote Cognitive Testing Tracks Early Alzheimer’s Decline - EMJ

Remote Cognitive Testing Detects Early Alzheimer’s Decline in Months

Frequent remote cognitive assessments detected subtle cognitive decline in people with early Alzheimer’s disease within just 30 weeks.

CML

Young Patients with CML Face Higher TKI Resistance: EHA 2026

Learn why young patients with CML show higher rates of first-line TKI resistance than older patients.